단국대학교 치과대학 부속치과병원에서 시행된 정주진정에 대한 연구

A Study of Intravenous Sedation in Dankook University Dental Hospital

  • 오정은 (단국대학교 치과대학 부속치과병원 소아치과) ;
  • 김종수 (단국대학교 치과대학 부속치과병원 소아치과) ;
  • 김승오 (단국대학교 치과대학 부속치과병원 치과마취과)
  • O, Jeong Eun (Department of Pediatric Dentistry, School of Dentistry, Dankook University Dental Hospital) ;
  • Kim, Jong-Su (Department of Pediatric Dentistry, School of Dentistry, Dankook University Dental Hospital) ;
  • Kim, Seung-Oh (Department of Dental Anesthesiology, School of Dentistry, Dankook University Dental Hospital)
  • 투고 : 2013.03.26
  • 심사 : 2013.04.01
  • 발행 : 2013.03.30

초록

Background: Intravenous sedation is effective for dental patients who are anxious. Recently, target-controlled infusion (TCI) has begun to be used widely to administer and titrate propofol and remifentanil during sedation. To investigate the effect and safety of the pharmacologic agents used in anesthetic department, we performed a retrospective study. Methods: Retrospective study of a series of dental procedure under intravenous sedation performed in department of anesthesiology in Dental Hospital of Dankook University was carried out with propofol or propofol/remifentanil between January and August 2011 and January and April 2012. All patients received oxygen by nasal cannula. The average propofol and remifentanil target was 0.5 ${\mu}g/ml$ and 1.0 ng/ml, respectively using a TCI pump. The average peripheral oxygen saturation ($SpO_2$), heart rate, blood pressure, respiratory rate, nasal end-tidal $CO_2$ were recorded at 5-10 minute intervals. The age, gender, weight, procedure and sedation time, type of procedure were also recorded. Results: We included 22 cases of 19 adults (group A) and 6 cases of children (group B). In group A, 4 patients received propofol (group A-P), and 15 patients received propofol with remifentanil (group A-PR). In group B, 6 patients received propofol only. The mean age of group A was 41.1 years old and that of group B was 9.5 years old. No clinically significant complications were noted. There were no case of de-saturation <90%. The median respiratory rate was 13.1 (range 6 to 36) in group A and 19 (range 13 to 25) in group B. The median end tidal $CO_2$ was 36.7 mmHg(range 8 mmHg to 56 mmHg) in group A and 41.7 mmHg (range 30 mmHg to 53 mmHg) in group B. Conclusions: Based on our results, dental sedation using propofol/remifentanil in adult and propofol in children with TCI pump seems to appear as a safe and effective procedure while performing dental procedure.

키워드

참고문헌

  1. Miligrom P, Weinstein P: Treating fearful dental patients, Seattle, 1996, University of Washington in Seattle, Continuing Dental Education.
  2. Murray JB: The puzzle of pain. Percept Motor Skills 1969; 28: 887-99. https://doi.org/10.2466/pms.1969.28.3.887
  3. Jones A, Bentler PM, Petry G: The reaction of uncertainty concerning future pain. J Abnorm Psychol. 1966; 71(2): 87-94. https://doi.org/10.1037/h0023115
  4. Kwak HJ, Kim JY, Kwak YL, Park WS, Lee KC: Comparison of a bolus of fentanyl with an infusion of alfetanil during target-controlled propofol infusion in third molar extraction under conscious sedation. J Oral Maxillofac Surg 2006; 64: 1577-82. https://doi.org/10.1016/j.joms.2005.11.112
  5. Whitman JG: Co-induction of anaesthesia: day-case surgery. Eur J Anaesthesiol Suppl 1995; 12: 25-34.
  6. Glass PS, Dyar OJ, Jacobs JR, Reves JG: Intravenous anesthetic drugs: infusion regimens. int anesthesiol Clin 1991; 29: 73-82. https://doi.org/10.1097/00004311-199102940-00007
  7. Alvarez AO, Cascardo A, Albarracin Menendez S, Capra JJ, Corsero RA: Total intravenous anesthesia with midazolam, remifentanil, propofol and cisatracurium in morbid obesity. Obesity Surgery 2000; 10: 353-60. https://doi.org/10.1381/096089200321629120
  8. Rai MR, Parry TM, Dombrobskis A, Warner OJ: Remifentanil target-controlled infusion vs propofol targetcontrolled infusion for conscious sedation for awake fibreoptic intubation: a double-blinded randomized controlled trial. Br J Anaesth 2008; 100: 125-30. https://doi.org/10.1093/bja/aem279
  9. Van Wijk AJ, Hoogstraten J: Reducing fear of pain associated with endodontic therapy. Int Endod 2006; 39: 384-8. https://doi.org/10.1111/j.1365-2591.2006.01090.x
  10. Holzman RS, Cullen DJ, Eichhorn JH, Philip JH: Guidelines for sedation by nonanesthesiologists during diagnostic and therapeutic procedures. J Clin Anesth 1994; 6: 265-76. https://doi.org/10.1016/0952-8180(94)90072-8
  11. Joseph E. Cillo, Jr: Hemodynamics in eldery coronary artery disease patients undergoing propofol sedation. J Oral Maillofac Surg 2006; 64: 1338-42. https://doi.org/10.1016/j.joms.2006.05.018
  12. Mcurray TJ, Johnston JR, Miligan KR, Grant IS, Mackenzie SJ, Sersin F, et al: Propofol sedation using Diprifusor target-controlled infusion in adult intensive care unit patients. Anaesthesia, 2004; 59: 636-41. https://doi.org/10.1111/j.1365-2044.2004.03745.x
  13. De Castro V, Godet G, Mencia M, Raux M, Coriat P: Target controlled infusion for remifentanil in vascular patients improves hemodynamics and decreases remifentanil requirement. Anesth Analg 2003; 96: 33-8.
  14. Bang BY, Shin TJ, Seo KS, Kim HJ: Target controlled conscious sedation with ropofol and remifentanil for the extraction of impacted wisdom teeth. JKDSA 2010; 10: 159-65.
  15. Cafiero T, Esposito F, Fraioli G, Gargiulo G, Frangiosa A, Cavallo LM, et al: Remifentanil-TCI and propofol-TCI for conscious sedation during fiberoptic intubation in the acromegalic patient. Eur J Anaesthesiol 2008; 25(8): 670-4. https://doi.org/10.1017/S0265021508004195
  16. Lallo A, Billard V, Bourgain JL: A comparison of propofol and remifentanil target-controlled infusions to facilitate fiberoptic nasotracheal intubation. Anesth Analg 2009; 108: 704-6. https://doi.org/10.1213/ane.0b013e3181954146
  17. Sebel PS, Lowdon JD: Propofol: A new intravenous anesthetic. Anesthesiology 1989; 71: 260. https://doi.org/10.1097/00000542-198908000-00015
  18. Paul G. Barash: Clinical anesthesia. 5th ed. London, Lippincott Williams & Wilkins. 2006, pp 269-70, 341-2, 371, 375.
  19. Keidan I, Berkensatat H, Sidi A: Propofol/remifentanil versus propofol alone for bone marrow aspiration in paediatric haemato oncological patients. Paediatr Anaesth 2001; 11: 297-301. https://doi.org/10.1046/j.1460-9592.2001.00662.x
  20. Dar AQ, Shah ZA: Anesthesia and sedation in pediatric gastrointestinal endoscopic procedures: A review. World J Gastrointest Enodsc 2010; 2(7): 257-62. https://doi.org/10.4253/wjge.v2.i7.257
  21. Sammartino M, Garra R, Sbaraglia F, De Riso M, Continolo N: Remifentanil in children. Pediatirc Anaesth 2010; 20: 246-55. https://doi.org/10.1111/j.1460-9592.2009.03241.x
  22. Anderson JA: State of the art respiratory monitoring for outpatient general anesthesia for oral surgery. Journal of Oral and Maxillofacial Surgery 1989; 47(Suppl 1): 50-1.
  23. Lightdale JR, Goldmann DA, Feldman HA, Newburg AR, DiNardo JA, Fox VL: Microstream capnography improves patient monitoring during moderate sedation: a randomized, controlled trial. Pediatrics 2006; 117 :1170-8. https://doi.org/10.1542/peds.2005-1709
  24. Anderson JL, Junkins E, Pribble C, Guenther E: Capnography and depth of sedation during propofol sedation in children. Ann Emerg Med 2007; 49: 9-13. https://doi.org/10.1016/j.annemergmed.2006.06.011
  25. James R, William H, David P: End-tidal carbon dioxide monitoring during procedural sedation. Academic emergency medicine 2002; 9: 275-80. https://doi.org/10.1111/j.1553-2712.2002.tb01318.x